BioNTech SE (BNTX) Current Assets (2018 - 2026)

BioNTech SE has reported Current Assets for 8 years, with the latest figure at $18.8 billion in Q4 2025.

• Quarterly Current Assets fell 6.46% year-over-year to $18.8 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $18.8 billion (down 6.46% YoY) and the FY2025 annual result came in at $18.2 billion, down 9.21% from the prior year.
• Current Assets grew to $18.8 billion in Q4 2025 per BNTX's latest filing, from $18.5 billion in the prior quarter.
• Over five years, Current Assets peaked at $22.4 billion in Q4 2022 and troughed at $4.3 billion in Q1 2021.
• A 5-year average of $18.5 billion and a median of $20.0 billion in 2024 frame the typical range for Current Assets.
• The sharpest annual moves came in 2021 and 2025: Current Assets surged 1385.59% in 2021, then retreated 17.21% in 2025.
• Over 5 years, Current Assets stood at $17.2 billion in 2021, then grew by 29.72% to $22.4 billion in 2022, then slipped by 6.06% to $21.0 billion in 2023, then dropped by 4.36% to $20.1 billion in 2024, then retreated by 6.46% to $18.8 billion in 2025.
• According to Business Quant data, Current Assets over the past three periods registered $18.8 billion, $18.5 billion, and $18.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.